首页|Biodegradable PTX-PLGA-coated magnesium stent for benign esophageal stricture: An experimental study
Biodegradable PTX-PLGA-coated magnesium stent for benign esophageal stricture: An experimental study
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Biodegradable stents can degrade step by step and thereby avoid secondary removal by endoscopic procedures in contrast to metal stents. Herein, a biodegradable composite stent, a magnesium (Mg)-based braided stent with a surface coating of poly (lactic-co-glycolic acid) (PLGA) containing paclitaxel (PTX), was designed and tested. By adding this drug-loaded polymer coating, the radial force of the stent increased from 33 Newton (N) to 83 N. PTX was continuously released as the stent degraded, and the in vitro cumulative drug release in phosphate-buffered saline for 28 days was 115 +/- 13.5 mu g/mL at pH = 7.4 and 176 +/- 12 mu g/mL at pH = 4.0. There was no statistically significant difference in the viability of fibroblasts of stent extracts with different concentration gradients ( P > 0.05), while the PTX-loaded stents effectively promoted fibroblast apoptosis. In the animal experiment, the stents were able to maintain esophageal patency during the 3-week follow-up and to reduce the infiltration of inflammatory cells and the amount of fibrous tissue. These results showed that the PTX-PLGA-coated Mg stent has the potential to be a safe and effective approach for benign esophageal stricture.
NSTL
Elsevier
